CC
AGN

Coastland Capital’s Allergan plc AGN Stock Holding History

Coastland Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-166,250
Closed -$34.9M – 118
2016
Q4 		$34.9M Buy
+166,250
New +$34.4M 0.96% 31
2016
Q2 		– Sell
-151,950
Closed -$40.7M – 119
2016
Q1 		$40.7M Buy
+151,950
New +$43.5M 1.95% 16
2014
Q4 		– Sell
-7,000
Closed -$1.75M – 171
2014
Q3 		$1.69M Buy
+7,000
New +$1.57M 0.06% 109
2014
Q2 		– Sell
-500
Closed -$104K – 154
2014
Q1 		$103K Buy
+500
New +$99K ﹤0.01% 121

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Coastland Capital's AGN Position: Q1 2017 in Review

Coastland Capital sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 166,250 shares — an estimated $34.9M sold.

Coastland Capital first reported a position in AGN in Q1 2014 and held it in 4 quarters. The position peaked at $40.7M in Q1 2016. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Coastland Capital reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Coastland Capital sold 166,250 Allergan plc shares in Q1 2017, an estimated $34.9M.
  • Coastland Capital first reported a position in Allergan plc in Q1 2014 and held it in 4 quarters.
  • Coastland Capital's Allergan plc position peaked at $40.7M in Q1 2016.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Coastland Capital's 13F filing for Q1 2017, filed 15 May 2017.